Subject:-: Community Health Nursing
Subject:-: Community Health Nursing
Health Nursing
Topic:- Epidemiology
PRESENTED BY,
MR. KAILASH NAGAR
ASSIST. PROF.
DEPT. OF COMMUNITY HEALTH NSG.
DINSHA PATEL COLLEGE OF NURSING, NADIAD
1. Introduction to Epidemiology
2
Definitions
[email protected] 3
Definitions…
Public health
4
Definitions…
Epidemiology
[email protected] 5
Components of the definition
Epidemiology is a science
[email protected] 6
Components…
[email protected] 7
Components…
[email protected] 8
Components…
[email protected] 9
Components…
[email protected] 10
Components…
6. Human population
[email protected] 11
Components…
7. Application
[email protected] 12
History of Epidemiology
[email protected] 13
History…
[email protected] 14
History…
[email protected] 15
Scope of Epidemiology
How?
1. Elucidation of natural history of diseases
2.Description of health status of population
3. Establishing determinants of diseases
4. Evaluation of intervention effectiveness
[email protected] 17
Types of Epidemiology
1.Descriptive Epidemiology
[email protected] 18
Types…
2. Analytic Epidemiology
[email protected] 19
Basic Epidemiological assumptions
[email protected] 20
Basic features of Epidemiology
[email protected] 21
2. Communicable disease
Epidemiology
[email protected] 22
Disease causation
[email protected] 23
Theories of disease causality
[email protected] 24
Theories…
[email protected] 25
Necessary Vs Sufficient
[email protected] 26
Etiology of a disease
[email protected] 27
Disease models
1.Epidemiological triangle
The interaction of an agent and host in an appropriate
environment results in disease
[email protected] 28
Disease models…
2. Web of causation
Complex interaction of factors results in disease
3. Wheel model
The hub (host) having a genetic make up as its core,
surrounded by an environment schematically divided in
to biological, physical and social
[email protected] 29
Natural history of disease
[email protected] 30
Natural history…
[email protected] 31
Levels of disease prevention
[email protected] 32
Levels of disease…
2. Secondary prevention
[email protected] 33
Levels of disease…
3. Tertiary prevention
[email protected] 34
Infectious disease process
[email protected] 35
The agent
Possible outcomes of exposure to an infectious agent
[email protected] 36
The agent…
[email protected] 37
Reservoir Vs Carrier
Reservoir
An organism or habitat in which an infectious
agent normally lives, transforms, develops and/or
multiplies
Carrier
A person who doesn’t have apparent clinical
disease, but is a potential source of infection to
other people
[email protected] 38
Types of carriers
[email protected] 39
Types of carriers…
[email protected] 40
Importance of carriers
[email protected] 41
Effect of carriers on disease transmission
[email protected] 42
Modes of disease transmission
1.Direct transmission
Direct contact: physical contact with body part of
infected person: Touching, kissing,biting,sex
Example: HIV
Direct projection: projection of saliva droplets
while coughing, sneezing,spitting,talking,singing
etc
Example: Common cold
Transplacental: Transmission from mother to
fetus through the placenta
Example: Syphilis
[email protected] 43
Modes of disease…
2. Indirect transmission
Vehicle-borne: transmission through inanimate
objects/non-living substances e.g HIV by needles
[email protected] 44
Modes of disease…
[email protected] 45
Importance of mode of transmission
[email protected] 46
Herd immunity
[email protected] 47
Conditions under which herd immunity best
functions
1. Single reservoir
2. Direct transmission
3. Total immunity
4. No carrier state
5. Uniform distribution of immunes
6. No overcrowding
[email protected] 48
Time course of an infectious disease
[email protected] 50
Application of time periods
• Pre-patent period
– When should we investigate?
• Incubation period
– When was time of exposure?
• Communicable period
– When should we take care of infectiousness?
• Latent period
– When would relapse occur?
• Convalescent period
– When,after recovery an individual becomes non-infectious?
• Generation time
– When is the maximum risk for contacts?
[email protected] 51
Factors which influence the development of
disease
Strain of the agent
Dose of the agent
Route of infection
Host age, nutritional status, immune status
Influence of treatment
Influence of season
[email protected] 52
3. Measures of disease
occurrence
[email protected] 53
What are measures of disease occurrence?
[email protected] 54
How do we measure diseases?
[email protected] 55
Descriptors
[email protected] 56
Descriptors
[email protected] 57
Which community is more affected?
[email protected] 58
When we call..
[email protected] 59
Types of rates
1. Crude rates: Apply to the total population in a
given area
[email protected] 61
Incidence rate
The proportion of a population that develops a
disease overtime
[email protected] 62
Cumulative incidence
[email protected] 63
Practical challenges in measuring incidence rate
[email protected] 64
Practical solution to the challenges
[email protected] 65
Prevalence rate
Two types
1. Point prevalence rate
2. Period prevalence rate
[email protected] 66
Point prevalence rate
Measures the proportion of a population with
a disease at a point in time
[email protected] 67
Period prevalence rate
[email protected] 68
Incidence Vs prevalence
[email protected] 70
Mortality rates
[email protected] 71
Common Mortality rates
[email protected] 72
4. Measures of association
[email protected] 73
2X2 table
Disease
No (+) c d c+d
[email protected] 74
Cells
[email protected] 75
Totals
Marginal totals
a+b= Exposed
c+d= Non-exposed
a+c= Diseased
b+d= Non-diseased
Grand total
n = a+b+c+d
[email protected] 76
Chi-square statistics
[email protected] 78
Importance of Chi-square
[email protected] 79
Relative risk (RR)
RR= a/(a+b)
c/(c+d)
[email protected] 80
Interpretation of relative risk
[email protected] 81
Strength of association
High if RR>3
Moderate if RR is between 1.5 & 2.9
Weak if RR is between 1.2 & 1.4
[email protected] 82
Odds ratio (OR)
Odds=P(E)/P(E’)=P(E)/(1-P(E))
[email protected] 83
Odds ratio…
Odds of exposure among exposed=a/c
Odds of exposure among non-diseased=b/d
OR= (a/c)/(b/d)
OR= ad/bc (it is also called cross-product ratio)
[email protected] 84
Odds ratio…
[email protected] 85
Attributable Risk (AR)
AR indicates how much of the risk is due to
/attributable/ to the exposure
[email protected] 87
Attributable risk percent (AR%)
[email protected] 88
Interpretation of AR%
[email protected] 89
Population Attributable Risk (PAR)
[email protected] 90
Population attributable risk percent (PAR%)
[email protected] 91
Possible outcomes in studying the relationship
between exposure & disease
1. No association
RR=1
AR=0
2. Positive association
RR>1
AR>0
3. Negative association
RR<1 (fraction)
AR<0 (Negative)
[email protected] 92
Risk Vs Preventive factors
[email protected] 93
5. Evaluation of Evidence
(Judgment of causality)
[email protected] 94
Association Vs Causation
[email protected] 95
Possible explanations for observed association
1. Chance
2. Bias
3. Confounding
4. Reverse causation
5. Reciprocal causation
6. Cause-effect relationship
[email protected] 96
Accuracy of measurement
[email protected] 97
Types of validity
Internal validity:
Is the degree to which a measured value is true within
the sample
External validity:
Is the extent to which a measured value apply beyond
the sample
[email protected] 98
Precision
[email protected] 99
Judgment of causality
[email protected] 101
1. Test of statistical significance
[email protected] 102
Test of statistical…
[email protected] 103
2. Estimation of confidence interval
[email protected] 104
Role of bias
[email protected] 105
Selection bias
Any systematic error that arises in the process of
identifying the study population
It affects the representativeness of the study
It occurs when there is a difference between
sample and population with respect to a variable
[email protected] 106
Information/observation/bias
[email protected] 107
Ways to minimize bias
[email protected] 109
Effect of confounding
[email protected] 110
Control of confounding variables
[email protected] 111
Criteria to asses the strength of evidence for
cause and effect relationship
Observational studies have many biases and
confounding. Experimental studies if properly done
can show cause-effect relationship. But they are not
usually feasible due to ethical issues
[email protected] 112
Criteria to asses the strength…
1. Strength of association: The stronger the
association the more likely it is causal
[email protected] 114
6. Epidemiologic Study Designs
[email protected] 115
Study design
[email protected] 116
Types of Epidemiologic study designs
1. Descriptive studies
– Describe: who, when, where & how many
2. Analytic studies
– Analyse: How and why
[email protected] 117
Types…
1. Observational studies
– The investigator observes nature
– No intervention
2. Intervention/Experimental studies
– Investigator intervenes
– He has a control over the situation
[email protected] 118
Types…
[email protected] 119
Types…
1. Prospective
– Conducted forward in time
2. Retrospective
– Conducted backward in time
[email protected] 120
Types…
1. Qualitative studies
– Generate contextual data
– Also called exploratory studies
2. Quantitative studies
– Generate numerical data
– Also called explanatory studies
[email protected] 121
Types…
1. Community-based studies
– Conducted in communities
2. Institution-based studies
– Conducted in communities
3. Laboratory-based studies
– Conducted in major laboratories
[email protected] 122
Types…
1. Cross-sectional studies
2. Case-control studies
3. Cohort studies
4. Experimental studies
[email protected] 123
Cross-sectional studies
In this study design information about the status of
an individual with respect to presence/absence of
exposure and diseased is assessed at a point in time.
[email protected] 124
Cross-sectional…
[email protected] 125
Cross-sectional…
[email protected] 126
Cross-sectional…
• Antecedent-consequence uncertainty
“Chicken or egg dilemma”
• Data dredging leading to inappropriate comparison
• More vulnerable to bias
[email protected] 127
Cross-sectional…
[email protected] 128
Cross-sectional…
[email protected] 129
Case-control studies
[email protected] 130
Case-control…
[email protected] 131
Case-control…
Sources of cases
1. Hospitals (Health institution)
– Cost-less
– Bias-more
2. Population (Community)
– Cost-more
– Bias-less
[email protected] 132
Case-control…
[email protected] 133
Case-control…
[email protected] 134
Case-control…
[email protected] 135
Case-control…
1. Retrospective case-control
– Uses prevalent cases
– Increased sample size
– Difficult to establish temporal sequence
– Useful for rare outcomes
[email protected] 136
Case-control…
2. Prospective case-control
– Uses incident cases
– Establish temporal sequence
– Recall is not a serious problem
– Records are easily obtainable
[email protected] 137
Case-control…
[email protected] 138
Case-control…
[email protected] 139
Case-control…
[email protected] 140
Cohort studies
1. Prospective (classical)
– Outcome hasn’t occurred at the beginning of the study
– It is the commonest and more reliable
[email protected] 141
Cohort…
2. Retrospective (Historical)
[email protected] 142
Cohort…
1. Define exposure
2. Select exposed group
3. Select non-exposed group
4. Follow and collect data on outcome
5. Compare outcome b/n exposed & non-exposed
[email protected] 143
Cohort…
[email protected] 144
Cohort…
[email protected] 145
Experimental studies
[email protected] 146
Experimental…
2. Preventive trials
– Conducted on healthy people
– To determine the effect of prevention on risk
[email protected] 147
Experimental…
[email protected] 148
Experimental…
[email protected] 149
Experimental…
• Feasibility issues
– Getting adequate subjects
– Achieving satisfactory compliance
• Cost issues
– Experimental studies are expensive
[email protected] 150
Experimental…
– Randomization
– Blinding
– Placebo
[email protected] 151
Experimental…
[email protected] 152
Experimental…
[email protected] 153
Experimental…
[email protected] 154
7. Screening
[email protected] 155
Screening
[email protected] 156
Aims of screening program
[email protected] 157
Criteria for selecting diseases for screening
[email protected] 158
Criteria for establishing screening program
[email protected] 159
Screening tests
Diagnostic test
D+ D-
Screening test T+ a b a+b
T- c d c+d
a+c b+d n
[email protected] 160
Definitions of cells
[email protected] 161
Definition of totals
[email protected] 162
Test performance
Validity of a test
[email protected] 163
Test performance
A. Sensitivity of a test
• The ability of a test to correctly identify those who
have the disease
• The probability that a diseased individual will have
a positive test result
• The proportion of people with a disease who have
a positive test result
• True positive rate (TPR)
[email protected] 164
Test performance
[email protected] 165
Test performance
B. Specificity of a test
• The ability of a test to correctly identify those who
don’t have the disease
• The probability that a disease-free individual will
have a negative test result
• The proportion of people without the disease who
have a negative test result
• True negative rate (TNR)
[email protected] 166
Test performance
[email protected] 167
Test performance
[email protected] 168
Test performance
[email protected] 169
Test performance
[email protected] 170
Test performance
Prevalence of a disease
The proportion of individuals with a disease
Prior/pre-test probability of a disease
Prevalence = P (D+)
= (a+c)/n
Yield of a test
Proportion of cases detected by the screening program
Yield = a/n
[email protected] 171
Multiple testing
Parallel testing:
– Tests are given concurrently
– At least one positive indicates disease
– Results in
• Greater sensitivity
• Increased PVN
• Decreased specificity
[email protected] 172
Multiple testing
Serial testing:
– Tests are administered sequentially
– All positive indicates disease
– Results in
• Lower sensitivity
• Increased specificity
• Increased PVP
[email protected] 173
Reliability of a test
[email protected] 174
Reliability of a test
– Internal reliability
• Internal consistency reliability
– External reliability
• Alternate test reliability
• Test-retest reliability
[email protected] 175
Evaluation of a screening program
[email protected] 176
In general
[email protected] 177
Thank you!